Study on Protection of the Right to Health, Access to Medicines and the Construction of the Rule of Law for Medicine Patents
Journal Title: Annals of Bioethics & Clinical Applications - Year 2022, Vol 5, Issue 4
Abstract
The Access to Medicines is related to the basic rights of people's rights to life and health. It has been widely recognized by international conventions and has become a basic duty of the state to ensure and improve the level of citizens' access to medicines. At the same time, in the face of increasingly widespread uncertainties in modern society, building a fair and efficient legal system for medicines access is a necessary measure to promote citizens' trust in the government and maintain the legitimacy of power. In the conditions of 1.3 billion population and an unbalanced and inadequate economic development, China strives to ensure that its citizens’ medicines are economically affordable through continuous improvement of the legal system and arrangements, and to encourage local pharmaceutical companies to develop and manufacture better-quality medicines. On the premise of respecting the status of market players and property rights of pharmaceutical companies, China comprehensively uses diversified tools such as information, standards, market access, and competition law enforcement to establish a legal system for medicines accessibility from two channels: supply guarantee and price control. Particular attention is paid to the adjustment of the medical and social insurance and essential medicines systems. In recent years, China has focused on improving the pharmaceutical patent system, promoting the balanced development of local original research medicines and generic medicines, as well as the overall optimization and upgrading of the pharmaceutical industry through the protection of patent rights and appropriate restrictions. Driven by the economic and trade agreement reached between China and the United States in 2020, China's Patent Law will introduce a drug patent term extension system and a drug patent linkage system, and further improve the legal mechanism to encourage innovative activities of pharmaceutical companies.
Authors and Affiliations
Yang W, Hai Y* and Haitian M
Keywords
Related Articles
- EP ID EP745704
- DOI 10.23880/abca-16000245
- Views 43
- Downloads 0
The Nature of the Principle of Deterrence in the Nuclear Actions of the Islamic Republic of Iran
US foreign policy during the Obama administration, especially in the second term, has focused to resolve its international crises in the Middle East and tried to resolve the Iranian nuclear issue. In the current article,...
Features of Including the Religious Component in the Educational Process
The modern education system, solving the problems of training effective specialists and forming the necessary level of culture and civic loyalty of the individual, faces the need to pay attention to preparing students to...
The implications of the Lack of Coordination and Self-Centered political Goals in Public Health: An insight into Mexico’s Response to COVID-19: A Case Study Report
This manuscript aims to explore the problems that the lack of coordination, inadequate management of the COVID-19 pandemic and insufficient health policies may represent to assertively face the COVID-19 pandemic in Mexic...
Judicial Organization and Institutions in Cameroon: A Tripartite Classification
Justice is a service open to the public. It is thus arranged, like any structure that renders public service, in a manner that whoever seeks for it receives appropriate attention. The setting up and organization of judic...
The Influence of the Sophists on Rousseau's Thought
The Sophists were the creators of an important Enlightenment movement in ancient Greece, which characterized an era of great spiritual activity centred on the city of Athens in the 5th century BC. Century, in which time...